25
Apr
2023

Minakem

Exhibitor at CPHI North America 2023 stand 540
About Us

MINAKEM is specialized in custom manufacturing of complex, advanced intermediates and APIs and HAPIs under strict cGMP conditions for the pharmaceutical industry. All development and manufacturing activities are supported by highly skilled R&D technical centres, strong and state-of-the-art analytical services including solid form and QbD laboratories. The R&D team is dedicated to process development, organic synthesis and analysis, and works under a secrecy agreement. The total capacity of its multi-purpose plant (FDA inspected) is 290m3. Minakem performs reactions under extreme temperature (f...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • FR
  • 2015
    On CPHI since
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI North America 2023
  • April, 25-27, 2023
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 540

Products Featured at CPHI North America 2023

  • Esomeprazole Magnesium Trihydrate

    Product Esomeprazole Magnesium Trihydrate

    THERAPEUTICAL USE: Anti-Ulcer, Gastro-Intestinal, Disorder TreatmentREGULATORY DOCUMENTATION: CEP / US DMF
  • Esomeprazole Magnesium Dihydrate

    Product Esomeprazole Magnesium Dihydrate

    THERAPEUTICAL USE: Anti-Ulcer  Gastro-Intestinal  Disorder Treatment REGULATORY DOCUMENTATION: CEP
  • Budesonide Oral & Respiratory grades

    Product Budesonide Oral & Respiratory grades

    THERAPEUTICAL USE: Anti-Inflammatory, Anti-Allergic, Anti-AsthmaticREGULATORY DOCUMENTATION: CEP / US DMF
  • Rilpvirine Hydrochloride

    Product Rilpvirine Hydrochloride

    Therapeutical use : Treatment of HIV Infection Currently in development 
  • Formoterol

    Product Formoterol

    Therapeutical use : Management of asthma and COPD Currently in development